DrugPatentWatch Database Preview
Details for Patent: 8,579,865
Email this page to a colleague
See Plans and PricingWhich drugs does patent 8,579,865 protect, and when does it expire?
Patent 8,579,865 protects OTREXUP and is included in one NDA.
This patent has twelve patent family members in seven countries.
Summary for Patent: 8,579,865
| Title: | Hazardous agent injection system |
| Abstract: | Injection systems comprising a powered injector and one or more hazardous agents are disclosed. |
| Inventor(s): | Wotton; Paul (Stamford, CT), Sadowski; Peter L. (Woodbury, MN), Hayes; John William (Chaska, MN) |
| Assignee: | Antares Pharma, Inc. (Ewing, NJ) |
| Application Number: | 13/257,555 |
|
Patent Claim Types: see list of patent claims | Dosage form; Use; |
Drugs Protected by US Patent 8,579,865
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antares Pharma Inc | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-005 | Nov 7, 2014 | DISCN | Yes | No | Start Trial | Start Trial | Y | SUBCUTANEOUS INJECTION OF METHOTREXATE | Start Trial | |||
| Antares Pharma Inc | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-001 | Oct 11, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Y | SUBCUTANEOUS INJECTION OF METHOTREXATE | Start Trial | |||
| Antares Pharma Inc | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-006 | Mar 24, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Y | SUBCUTANEOUS INJECTION OF METHOTREXATE | Start Trial | |||
| Antares Pharma Inc | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-002 | Oct 11, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Y | SUBCUTANEOUS INJECTION OF METHOTREXATE | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,579,865
| PCT Information | |||
| PCT Filed | March 19, 2010 | PCT Application Number: | PCT/US2010/028011 |
| PCT Publication Date: | September 23, 2010 | PCT Publication Number: | WO2010/108116 |
International Family Members for US Patent 8,579,865
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2010226442 | Start Trial | |||
| Canada | 2755779 | Start Trial | |||
| China | 102612381 | Start Trial | |||
| European Patent Office | 2408493 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
